Trueblood Wealth Management’s Capital Group Core Equity ETF CGUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.98M Buy
66,958
+2,458
+4% +$105K 1.04% 15
2026
Q1
$2.48M Buy
64,500
+4,370
+7% +$176K 0.97% 17
2025
Q4
$2.42M Buy
60,130
+7,557
+14% +$302K 0.94% 16
2025
Q3
$2.08M Buy
52,573
+2,143
+4% +$82.3K 0.81% 23
2025
Q2
$1.86M Buy
50,430
+6,738
+15% +$230K 0.78% 28
2025
Q1
$1.46M Buy
43,692
+15,612
+56% +$548K 0.68% 41
2024
Q4
$982K Buy
28,080
+9,964
+55% +$349K 0.48% 66
2024
Q3
$621K Buy
18,116
+5,255
+41% +$174K 0.31% 102
2024
Q2
$415K Buy
12,861
+5,493
+75% +$172K 0.23% 126
2024
Q1
$230K Buy
+7,368
New +$218K 0.13% 197

Other funds holding CGUS

Trueblood Wealth Management's CGUS Position: Q2 2026 in Review

Trueblood Wealth Management increased its Capital Group Core Equity ETF (CGUS) stake by 3.8% in Q2 2026, buying an estimated $105K and bringing the position to 66,958 shares worth $2.98M. The position accounts for 1.04% of the portfolio, ranked #15.

Trueblood Wealth Management first reported a position in CGUS in Q1 2024 and has held it in 10 quarters since. 442 funds tracked by Wall St. Rank hold CGUS as of Q2 2026.

  • Trueblood Wealth Management held 66,958 shares of Capital Group Core Equity ETF worth $2.98M as of Q2 2026.
  • Trueblood Wealth Management bought 2,458 Capital Group Core Equity ETF shares in Q2 2026, an estimated $105K.
  • Capital Group Core Equity ETF made up 1.04% of Trueblood Wealth Management's portfolio in Q2 2026, its #15 holding.
  • Trueblood Wealth Management first reported a position in Capital Group Core Equity ETF in Q1 2024 and has held it in 10 quarters since.
  • 442 funds tracked by Wall St. Rank held Capital Group Core Equity ETF as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.